Full Press Release Details
Vesting of awards under the Long Term Incentive Plan
Hong Kong, Shanghai & Florham Park, NJ - Wednesday, March 11, 2026: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; SEHK:13) announces that following the announcement of the 2025 annual results of HUTCHMED on March 5, 2026, the following awards granted under the Long Term Incentive Plan ("LTIP") on June 5, 2023 to Dr Weiguo Su and Mr Johnny Cheng were vested on March 10, 2026:-
| Award Holders | Number of ordinary shares | |
| Person Discharging Managerial Responsibilities | ||
| Dr Weiguo Su (Executive Director, Chief Executive Officer and Chief Scientific Officer) | 524,079 | |
| Mr Johnny Cheng (Executive Director, Acting Chief Executive Officer and Chief Financial Officer) | 202,238 | |
| Total | 726,317 |
The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name | Dr Weiguo Su | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Executive Director, Chief Executive Officer and Chief Scientific Officer | |||
| b) | Initial notification/Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | HUTCHMED (China) Limited | |||
| b) | LEI | 2138006X34YDQ6OBYE79 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of US$0.10 Ordinary Share with DI ISIN: KYG4672N1016 | |||
| b) | Nature of the transaction | Vesting of awards granted on June 5, 2023 under HUTCHMED's LTIP | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| Nil | 524,079 ordinary shares | ||||
| d) | Aggregated information - Aggregated volume - Price | N/A | |||
| e) | Date of the transaction | 2026-03-10 | |||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name | Mr Johnny Cheng | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Executive Director, Acting Chief Executive Officer and Chief Financial Officer | |||
| b) | Initial notification/Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | HUTCHMED (China) Limited | |||
| b) | LEI | 2138006X34YDQ6OBYE79 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of US$0.10 Ordinary Share with DI ISIN: KYG4672N1016 | |||
| b) | Nature of the transaction | Vesting of awards granted on June 5, 2023 under HUTCHMED's LTIP | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| Nil | 202,238 ordinary shares | ||||
| d) | Aggregated information - Aggregated volume - Price | N/A | |||
| e) | Date of the transaction | 2026-03-10 | |||
| f) | Place of the transaction | Outside a trading venue |
| Investor Enquiries | +852 2121 8200 / ir@hutch-med.com |
| Media Enquiries | |
| FTI Consulting - | +44 20 3727 1030 / HUTCHMED@fticonsulting.com |
| Ben Atwell / Tim Stamper | +44 7771 913 902 (Mobile) / +44 7779 436 698 (Mobile) |
| Brunswick - Zhou Yi | +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com |
| Panmure Liberum | Nominated Advisor and Joint Broker |
| Atholl Tweedie / Emma Earl / Rupert Dearden | +44 20 7886 2500 |
| Cavendish | Joint Broker |
| Geoff Nash / Nigel Birks | +44 20 7220 0500 |
| Deutsche Numis | Joint Broker |
| Freddie Barnfield / Jeffrey Wong / Duncan Monteith | +44 20 7260 1000 |